Onkure Therapeutics, Stock Today
| OKUR Stock | 8.38 0.33 4.10% |
Performance0 of 100
| Odds Of DistressOver 81
|
OnKure Therapeutics, is selling at 8.38 as of the 21st of December 2024; that is 4.10% up since the beginning of the trading day. The stock's lowest day price was 7.73. OnKure Therapeutics, has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. OnKure Therapeutics, symbol was changed from RPHM on 7th of October 2024. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of December 2024. Click here to learn more.
IPO Date 7th of October 2024 | Category Healthcare |
OnKure Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange. More on OnKure Therapeutics,
Moving against OnKure Stock
OnKure Stock Highlights
| Older Symbol | RPHM | |||||||||||||||||||||||||||||||||||||||||||||
| CEO President | Nicholas Saccomano | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, NASDAQ Composite, NASDAQ Health Care, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
OnKure Therapeutics, (OKUR) is traded on NASDAQ Exchange in USA. It is located in 6707 Winchester Circle, Boulder, CO, United States, 80301 and employs 13 people. OnKure Therapeutics, was previously known as Reneo Pharmaceuticals and was traded on NASDAQ Exchange under the symbol RPHM. OnKure Therapeutics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company conducts business under Healthcare sector and is part of Biotechnology industry.
Check OnKure Therapeutics, Probability Of Bankruptcy
OnKure Therapeutics, Historical Income Statement
OnKure Stock Against Markets
OnKure Therapeutics, Corporate Management
| Kevin Litwiler | Senior Pharmacology | Profile | |
| Jason CPA | Chief Officer | Profile | |
| Pr Liu | Member Board | Profile | |
| Rogan JD | General Secretary | Profile | |
| Dylan Hartley | Chief Officer | Profile | |
| Richard Woessner | Senior Pharmacology | Profile |
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.